MS Ventures is the strategic venture capital fund of the healthcare business of Merck. The fund was established in March 2009 and focuses primarily on early stage investments. Metabomed is a drug discovery company in the field of cancer metabolism with a proprietary target identification platform based on computational biology and metabolomics. Metabomed focuses on the discovery of drugs that inhibit targets that form a synthetic lethal gene pair with metabolic genes inactivated in cancer cells.
View Top Employees from Metabomed| Website | http://www.ms-ventures.com |
| Revenue | $2 million |
| Employees | View employees |
| Address | 18 South Industrial ZoneHakishon, Yavne, Central District, IL |
| Industry | Business Services General, Business Services |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 541713 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies |
Looking for a particular Metabomed employee's phone or email?
Metabomed Questions
The Metabomed annual revenue was $2 million in 2024.
Metabomed is based in Yavne, Central District.
The NAICS codes for Metabomed are [541713, 54, 541, 54171, 5417].
The SIC codes for Metabomed are [873, 87].
